Income Statement
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) |
3 Months Ended | 6 Months Ended | |||||
|---|---|---|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
Jun. 30, 2018 |
Jun. 30, 2017 |
||||
| REVENUES | |||||||
| Real property rental | $ 278,872 | $ 222,254 | $ 575,495 | $ 222,254 | |||
| Medical related consulting services - related parties | 141,996 | 152,497 | 141,996 | 218,783 | |||
| Development services and sales of developed products | 75,225 | 86,515 | |||||
| Total Revenues | 496,093 | 374,751 | 804,006 | 441,037 | |||
| COSTS AND EXPENSES | |||||||
| Real property operating expenses | 195,941 | 161,854 | 406,215 | 161,854 | |||
| Medical related consulting services - related parties | 124,715 | 125,231 | 124,715 | 224,812 | |||
| Development services and sales of developed products | 42,093 | 58,613 | |||||
| Total Costs and Expenses | 362,749 | 287,085 | 589,543 | 386,666 | |||
| REAL PROPERTY OPERATING INCOME | 82,931 | 60,400 | 169,280 | 60,400 | |||
| GROSS PROFIT (LOSS) FROM MEDICAL RELATED CONSULTING SERVICES | 17,281 | 27,266 | 17,281 | (6,029) | |||
| GROSS PROFIT FROM DEVELOPMENT SERVICES AND SALES OF DEVELOPED PRODUCTS | 33,132 | 27,902 | |||||
| OTHER OPERATING EXPENSES: | |||||||
| Selling expense | 6,279 | 14,990 | |||||
| Compensation and related benefits | 487,452 | 205,473 | 1,026,266 | 388,400 | |||
| Professional fees | 593,025 | 172,705 | 1,164,797 | 379,923 | |||
| Other general and administrative | 266,121 | 91,927 | 551,373 | 152,659 | |||
| Total Other Operating Expenses | 1,346,598 | 476,384 | 2,742,436 | 935,972 | |||
| LOSS FROM OPERATIONS | (1,213,254) | (388,718) | (2,527,973) | (881,601) | |||
| OTHER INCOME (EXPENSE) | |||||||
| Interest income | 1,300 | 210 | 1,708 | 1,004 | |||
| Interest expense | (24,932) | (42,000) | (261,918) | (42,000) | |||
| Foreign currency transaction loss | (106,929) | (106,929) | (57,244) | ||||
| Other income | 328 | ||||||
| Total Other Expense, net | (130,561) | (41,790) | (366,811) | (98,240) | |||
| LOSS BEFORE INCOME TAXES | (1,343,815) | (430,508) | (2,894,784) | (979,841) | |||
| INCOME TAXES | |||||||
| NET LOSS | (1,343,815) | (430,508) | (2,894,784) | (979,841) | [1] | ||
| LESS: NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST | (49,421) | (118,811) | |||||
| NET LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS | (1,294,394) | (430,508) | (2,775,973) | (979,841) | |||
| COMPREHENSIVE LOSS | |||||||
| NET LOSS | (1,343,815) | (430,508) | (2,894,784) | (979,841) | |||
| Unrealized foreign currency translation (loss) gain | (96,207) | 7,647 | (43,369) | (32,124) | |||
| COMPREHENSIVE LOSS | (1,440,022) | (422,861) | (2,938,153) | (1,011,965) | |||
| LESS: COMPREHENSIVE LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST | (49,540) | (118,770) | |||||
| COMPREHENSIVE LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS | $ (1,390,482) | $ (422,861) | $ (2,819,383) | $ (1,011,965) | |||
| NET LOSS PER COMMON SHARE ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS | |||||||
| Basic and diluted | $ (0.02) | $ (0.01) | $ (0.04) | $ (0.02) | |||
| WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: | |||||||
| Basic and diluted | 71,979,678 | 64,628,622 | 71,122,536 | 63,617,572 | |||
| |||||||
| X | ||||||||||
- Definition Consulting services costs related parties paid during the period. No definition available.
|
| X | ||||||||||
- Definition Development services and sales of developed products. No definition available.
|
| X | ||||||||||
- Definition Development services and sales of developed products. No definition available.
|
| X | ||||||||||
- Definition Gross Profit From Development Services And Sales Of Developed Products. No definition available.
|
| X | ||||||||||
- Definition Medical related consulting services - related parties. No definition available.
|
| X | ||||||||||
- Definition Operating expenses related to real propert for the period. No definition available.
|
| X | ||||||||||
- Definition Operating income related to real propert for the period. No definition available.
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares. No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net amount of operating interest income (expense). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition Amount before tax of other comprehensive income (loss) attributable to parent entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Expenses recognized in the period that are directly related to the selling and distribution of products or services. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|
| X | ||||||||||
- References No definition available.
|
